EP1.01-03 Real World Outcome of Crizotinib for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1975 ◽

2019 ◽

Vol 14 (10) ◽

pp. S911

Author(s):

C. Choi ◽

Y.J. Kim ◽

J.C. Lee ◽

S. Kim ◽

D.H. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma

Download Full-text

Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2012.03.004 ◽

2012 ◽

Vol 77 (2) ◽

pp. 288-292 ◽

Author(s):

Heae Surng Park ◽

June Koo Lee ◽

Dong-Wan Kim ◽

Kimary Kulig ◽

Tae Min Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Alk Rearrangement ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma

Download Full-text

PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2013.778828 ◽

2013 ◽

Vol 14 (5) ◽

pp. 597-608 ◽

Author(s):

Sara Pilotto ◽

Umberto Peretti ◽

Silvia Novello ◽

Giulio Rossi ◽

Michele Milella ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma

Download Full-text

P1.14-32 Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer Patients Treated with Ensartinib

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1183 ◽

2019 ◽

Vol 14 (10) ◽

pp. S566

Author(s):

H. Wakelee ◽

K. Reckamp ◽

T. Leal ◽

A. Chiappori ◽

S. Waqar ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma

Download Full-text

J-ALEX trial will crown alectinib as the standard choice for anaplastic lymphoma kinase positive untreated non-small cell lung cancer patients?

Journal of Thoracic Disease ◽

10.21037/jtd.2017.12.76 ◽

2018 ◽

Vol 10 (1) ◽

pp. 106-108 ◽

Author(s):

Cesare Gridelli ◽

Francesca Casaluce ◽

Assunta Sgambato ◽

Giovanni Palazzolo ◽

Paolo Maione

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma

Download Full-text

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

OncoTargets and Therapy ◽

10.2147/ott.s144960 ◽

2017 ◽

Vol Volume 11 ◽

pp. 75-82 ◽

Author(s):

Marco D DiBonaventura ◽

William Wong ◽

Bijal Shah-Manek ◽

Mathias Schulz

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma ◽

Download Full-text

Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets

Chinese Clinical Oncology ◽

10.21037/cco.2018.09.03 ◽

2019 ◽

Vol 8 (S1) ◽

pp. S1-S1 ◽

Author(s):

Gianluca Spitaleri ◽

Antonio Passaro ◽

Filippo de Marinis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma ◽

Download Full-text

Pyrotinib in HER2 Heterogeneously Mutated or Amplified Advanced Non-small Cell Lung Cancer Patients: A Retrospective Real-world Study (PEARL)

Journal of the National Cancer Center ◽

10.1016/j.jncc.2021.08.001 ◽

2021 ◽

Author(s):

Guangjian Yang ◽

Xuezhi Hao ◽

Jiaqi Hu ◽

Keke Dong ◽

Haiyan Xu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Abstract 1616: Characterizing differences in checkpoint inhibitor biomarkers in a real-world cohort of stage III and IV non-small cell lung cancer patients

10.1158/1538-7445.am2021-1616 ◽

2021 ◽

Author(s):

Yinjie Gao ◽

Michelle M. Stein ◽

Prerna Jain ◽

Denise Lau ◽

Kimberly L. Blackwell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Checkpoint Inhibitor ◽

Stage Iii ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

Translational Lung Cancer Research ◽

10.21037/tlcr-21-681 ◽

2021 ◽

Vol 10 (9) ◽

pp. 3782-3792

Author(s):

Xin Yu ◽

Jiaqi Li ◽

Lingyun Ye ◽

Jing Zhao ◽

Mengqing Xie ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutant ◽

Download Full-text

FP10.01 The Efficacy of Immunotherapy in non-Small Cell Lung Cancer Patients with Uncommon Mutations: a Real World Research from Single Site

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.08.239 ◽

2021 ◽

Vol 16 (10) ◽

pp. S962

Author(s):

Y. Cheng ◽

Y. Zhang ◽

Y. Liu ◽

X. Liu ◽

C. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Single Site ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text